Healthcare
Psilocybin’s Antidepressant Effects Can Last Over 12 Months Says New Medical Study
Psilocybin’s Antidepressant Effects Are Long Lasting, Says Studies
Millions of people around the world rely on antidepressant medications just to get by.
There are dozens of different antidepressants in the pharmaceutical market, and in order to feel its effects, many need to be taken daily for up to 2 weeks to feel any significant improvements. In addition, these pills can often take from 3 up to 6 months for one to no longer feel depressed, if they even work for you. There are countless people who are unable to rely on the effects of antidepressants because they simply don’t work for them, or make them feel numb; oftentimes, antidepressants can even make you feel worse than you did to start.
The side effects of antidepressants vary: these can include insomnia, fatigue, headaches, diarrhea or constipation, dry mouth, and sexual problems, to name a few. Since depression can truly rob you of quality of life – so either way, it’s a risk.
But what if you only had to take one thing ONCE or twice a year, and notice significant improvements in depression already?
Psilocybin mushrooms may be able to do just that.
A study from earlier this year involved 27 participants, all of whom had a long history with depression. Many were experiencing symptoms of depression for around 2 years before they were recruited for the study, conducted by researchers at Johns Hopkins University, who were following up on previous studies that revealed psilocybin treatment was effective in treating depressive symptoms for up to a month.
Among the participants, 88% were treated with conventional antidepressant medications in the past while 58% said they were using antidepressants currently. After they were all screened, they were divided into two groups randomly, made to attend preparatory meetings, then given two doses of psilocybin 2 weeks apart from August 2017 through April 2019. They also came back to the Johns Hopkins Bayview Medical Center for follow-ups a day and a week after all sessions, followed by follow ups at 1, 3, 6, and 12 month intervals after the 2nd session. Twenty-four of these participants were able to complete all the psilocybin and follow-up visits.
According to the researchers, psilocybin treatment among both groups revealed that there were significant reductions in depression symptoms. The symptoms were also found to stay low for not just one and 3 months, but up to 12 months following treatment.
“Our findings add to evidence that, under carefully controlled conditions, this is a promising therapeutic approach that can lead to significant and durable improvements in depression,” explains Natalie Gukasyan, MD, the Johns Hopkins University School of Medicine assistant professor of psychiatry and behavioral sciences. She does warn that “the results we see are in a research setting and require quit a lot of preparation and structured support from trained clinicians and therapists, and people should not attempt to try it on their own.”
“Psilocybin not only produces significant and immediate effects, it also has a long duration, which suggests that it may be a uniquely useful new treatment for depression,” adds Roland Griffiths, Ph.D., founding director of the Johns Hopkins Center for Psychedelic and Consciousness Research, and a Professor in Neuropsychopharmacology of Consciousness. “Compared to standard antidepressants, which must be taken for long stretches of time, psilocybin has the potential to enduringly relieve the symptoms of depression with one or two treatments.”
Given the track record of standard antidepressants, this is incredible news.
However, the researchers highlight the importance of doing more research to verify that psilocybin is indeed effective enough to last for more than 12 months.
Older Studies
There have been similar older studies done that show similar results.
For one, NYU Grossman School of Medicine researchers followed up on the results of their 2016 study which found that just a one-time treatment of single dose psilocybin was effective in delivering significant improvements for the mental well-being of patients who had cancer.
The cancer patients suffered from existential dread, anxiety, depression, and hopelessness. However, after following up 6.5 months after treatment, they found that psilocybin treatment was associated with better quality of life, improvement in spiritual wellbeing, and decreases in anxiety and depression.
“Our results represent the strongest evidence to date of a clinical benefit from psilocybin therapy, with the potential to transform care for patients with cancer-related psychological distress,” explains Stephen Ross, MD, the study’s lead author. “If larger clinical trials prove successful, then we could ultimately have available a safe, effective, and inexpensive medication – dispensed under strict control – to alleviate the distress that increases suicide rates among cancer patients,” Ross adds.
One of the most important findings of their study was that the clinical scores for depression and anxiety lasted for 8 months – which was far longer than the monitoring period for the study. Study co-author Anthony Bossis, PhD, also said that the patients reported greater improvements in quality of life following psilocybin treatment: they had more energy, went out more, performed better at work, and had better relationships with family members. Some patients even said that they were more spiritual in various ways, experienced unusual peacefulness, and had feelings of altruism.
“Our study showed that psilocybin facilitated experiences that drove reductions in psychological distress,” Bossis said. “And if it’s true for cancer care, then it could apply to other stressful medical conditions.”
Conclusion
Psilocybin is proving to be a remarkable, revolutionary compound in the world of medicine. As of today, it already has found so many far-reaching uses with deep impacts on the lives of people struggling with emotional and mental health. It might not be a panacea, but it is a fantastic starting point that may potentially have long-lasting effects.
Economic Fraud
Fugitive Medicare Fraud Suspect Returned to US After Arrest in Türkiye
U.S. federal authorities have secured the return of a fugitive suspect accused of involvement in a massive Medicare fraud operation, following his arrest in Türkiye. The extradition marks a significant development in a major healthcare fraud investigation that allegedly cost the American healthcare system billions of dollars.
The suspect, Ibrahim Khaldoon Hilmi, is now in federal custody after spending more than a year outside the United States. Prosecutors are expected to move forward with criminal proceedings as investigators continue to examine what authorities describe as a sophisticated fraud network targeting public healthcare funds.
International Manhunt Ends with Arrest in Türkiye
According to federal investigators, Hilmi left the United States in May 2025 while authorities were building their case. Law enforcement agencies later tracked his location to Türkiye, where cooperation between U.S. and Turkish officials led to his detention.
Following the completion of legal and diplomatic procedures, the suspect was transferred to American custody. Officials described the operation as a successful example of international law enforcement collaboration in pursuing suspects accused of large-scale financial crimes.
A specialized FBI team reportedly traveled to Türkiye to coordinate the transfer and ensure the extradition process was completed smoothly.
Alleged Scheme Targeted Medicare Reimbursement System
Investigators allege that Hilmi played a central role in a fraudulent operation that exploited the Medicare reimbursement system through false claims and improper billing practices.
Authorities estimate that the alleged scheme involved financial losses equivalent to approximately ₹31,700 crore, making it one of the most significant healthcare fraud investigations in recent years.
While the allegations have yet to be tested in court, investigators believe the operation relied on complex financial transactions and coordinated activities designed to extract funds from a government healthcare program serving millions of beneficiaries.
Federal Agencies Expand Investigation
The case extends beyond a single suspect. Federal authorities are examining the potential involvement of additional individuals, businesses, and organizations believed to be connected to the alleged fraud network.
Investigators are reviewing banking records, financial transactions, corporate structures, and digital evidence to determine the full scope of the operation and identify any additional participants.
Officials indicated that tracing the movement of funds and uncovering potential links between entities remains a key focus of the ongoing investigation.
Healthcare Fraud Remains a Major Concern
Government agencies continue to treat Medicare fraud as a serious threat because it impacts taxpayer-funded healthcare resources intended for legitimate medical services.
Authorities argue that fraudulent claims can divert critical funding, increase administrative costs, and place additional pressure on public healthcare programs. As healthcare systems become increasingly digitized, fraud schemes have also become more sophisticated and difficult to detect.
Financial crime specialists note that modern healthcare fraud investigations often involve shell companies, layered transactions, and cross-border financial networks that require extensive forensic analysis.
Growing Importance of Global Law Enforcement Cooperation
The successful return of Hilmi highlights the increasing role of international cooperation in combating financial crime. Law enforcement agencies worldwide are relying more heavily on cross-border partnerships to locate and apprehend suspects who attempt to evade prosecution by relocating overseas.
Officials say such collaborations are essential as financial crimes become increasingly global in nature, involving multiple jurisdictions and complex international money flows.
Legal Proceedings Ahead
The U.S. Department of Justice is expected to present evidence against the suspect as court proceedings move forward. Prosecutors will seek to establish the extent of the alleged fraud and determine accountability among those involved.
The outcome of the case could influence future enforcement efforts aimed at protecting public healthcare programs and strengthening safeguards against large-scale financial misconduct.
For federal authorities, the extradition of Ibrahim Khaldoon Hilmi represents a major step in an ongoing campaign to crack down on healthcare fraud and recover public funds allegedly lost through criminal schemes.
Cyber Crime
Telangana Doctors Lose Nearly ₹30 Crore to Cyber Fraud Since September 2024
Cybercriminals have defrauded doctors across Telangana of nearly ₹30 crore since September 2024, prompting authorities to strengthen awareness campaigns and cybersecurity education within the healthcare sector.
The alarming figures were revealed during a cyber awareness programme organized by the Telangana Cyber Security Bureau (TGCSB) in Hyderabad. Senior officials warned that healthcare professionals are increasingly becoming targets of sophisticated online scams despite their educational and professional backgrounds.
Healthcare Professionals Under Growing Cyber Threat
Addressing representatives from various medical associations, TGCSB Director Shikha Goel highlighted the rising number of cybercrime incidents involving doctors and healthcare workers. She emphasized that cybercriminals are exploiting digital platforms to target individuals across all professions, including highly qualified medical practitioners.
Officials stressed that vigilance, awareness, and prompt reporting remain the strongest defenses against cyber fraud. The event focused on strengthening cooperation between law enforcement agencies and the medical fraternity to improve preparedness against evolving cyber threats.
More than 70 office-bearers from medical organizations across Telangana attended the session, including presidents, secretaries, treasurers, and senior representatives.
Investment Scams Responsible for Major Financial Losses
According to TGCSB data, at least 735 doctors have reported cybercrime-related incidents since September 2024, with total losses reaching approximately ₹29.88 crore.
Business and investment fraud emerged as the most damaging category, accounting for losses of ₹22.39 crore involving 127 victims. Investigators noted that fraudsters often lure professionals with promises of high returns, fake investment opportunities, and deceptive business schemes.
Authorities also reported a wide range of other cyber offences affecting doctors, including digital arrest scams, identity theft, impersonation fraud, fake advertisements, job-related scams, insurance fraud, cryptocurrency fraud, UPI-related cheating, matrimonial scams, and sextortion cases.
Authorities Stress Importance of Rapid Reporting
The Telangana Cyber Security Bureau urged victims to report cybercrime incidents immediately, especially during the critical “golden hour” after a fraudulent transaction occurs.
Officials explained that timely complaints through the national cybercrime helpline 1930 and the official cybercrime reporting portal can significantly improve the chances of freezing suspicious transactions and recovering stolen funds.
The bureau further warned that cybercriminals are employing increasingly advanced techniques to deceive victims, making awareness and quick action more important than ever.
Medical Associations Join Awareness Drive
Representatives from associations of paediatricians, cardiologists, dentists, orthopaedic surgeons, gynaecologists, and hospital administrators participated in the discussions. The groups pledged to work closely with authorities to spread cybersecurity awareness through hospitals, clinics, medical conferences, and professional training programmes.
Officials believe that expanding cyber awareness among healthcare professionals will play a key role in reducing financial fraud and strengthening digital security across the state’s medical community.
As cyber threats continue to evolve, law enforcement agencies are encouraging doctors and other professionals to remain cautious when responding to investment offers, unknown communications, and requests for sensitive financial information online.
Education News
AIIMS Gorakhpur Reservation Controversy: FIR Alleges Fake OBC Certificate Used Despite ₹80 Lakh Income
A major controversy has emerged at AIIMS Gorakhpur after allegations surfaced that reservation benefits were misused to secure a postgraduate medical seat. A criminal case has been registered against former AIIMS Gorakhpur Executive Director Dr. G.K. Pal and his son, Dr. Oro Prakash Pal, over the alleged use of a forged Other Backward Class (OBC) Non-Creamy Layer certificate for admission to an MD course.
The case has triggered widespread debate within medical and administrative circles, raising serious questions about transparency and oversight in admissions to premier medical institutions.
FIR Filed on Court’s Direction
The First Information Report (FIR) was registered at the AIIMS police station following directions from Chief Judicial Magistrate Tvishi Srivastava. According to the complaint, the alleged offence took place on August 30, 2024, when forged documents were purportedly used to obtain an MD seat under the OBC reservation quota.
Sources indicate that the matter was subsequently brought to the attention of the Union Ministry of Health, prompting internal reviews and administrative action.
Alleged Income Far Above Eligibility Threshold
Central to the allegations is the claim that Dr. G.K. Pal and his wife Parvati Pal have a combined annual income exceeding ₹80 lakh. Under existing reservation rules, families with such income levels are not eligible for OBC Non-Creamy Layer benefits.
Following the emergence of the controversy, Dr. Pal was first removed from his position at AIIMS Gorakhpur and later relieved of responsibilities at AIIMS Patna. He is currently posted at JIPMER Puducherry. With the registration of the FIR, officials suggest that further legal and departmental action may follow, depending on the outcome of the investigation.
Complaint Highlights Systemic Concerns
The complaint was filed by Ashutosh Kumar Mishra, a resident of Divyanagar in the Cantonment area. He alleged that the events related to the case occurred between January and September 2024. The complainant argued that misuse of reservation provisions by individuals in senior positions undermines the integrity of public institutions and erodes trust in the medical education system.
The case has reignited concerns over whether verification mechanisms for reservation certificates are robust enough, particularly in high-stakes admissions.
Impact on Medical Community
The allegations have sent shockwaves through the medical fraternity. Experts believe that if the claims are substantiated, the case could prompt a broader review of admission procedures and lead to stricter scrutiny of category certificates across institutions like AIIMS.
Authorities have stated that all relevant documents will be carefully examined before taking further steps. The outcome of the investigation is expected to have far-reaching implications for accountability and compliance in medical admissions.
Questions Await Answers
As the probe continues, several key issues remain unresolved: whether reservation norms were deliberately violated, how verification processes failed, and whether similar cases may surface in the future. For now, the focus remains on the investigation and its potential consequences.
-
Business3 years agoPot Odor Does Not Justify Probable Cause for Vehicle Searches, Minnesota Court Affirms
-
Business3 years agoNew Mexico cannabis operator fined, loses license for alleged BioTrack fraud
-
Business3 years agoAlabama to make another attempt Dec. 1 to award medical cannabis licenses
-
Business3 years agoWashington State Pays Out $9.4 Million in Refunds Relating to Drug Convictions
-
Business3 years agoMarijuana companies suing US attorney general in federal prohibition challenge
-
Business3 years agoLegal Marijuana Handed A Nothing Burger From NY State
-
Business3 years agoCan Cannabis Help Seasonal Depression
-
Blogs3 years agoCannabis Art Is Flourishing On Etsy
